Abstract
Rationale A variety of behavioral procedures have been developed to assess cannabinoid activity in mice; however, the feasibility of establishing Δ9-THC as a discriminative stimulus in mice has not been documented. Objective One goal was to establish Δ9-THC as a discriminative stimulus in mice; after having done so, another goal was to examine the in vivo mechanism of action of Δ9-THC with other cannabinoids and noncannabinoids. Materials and methods C57BL/6J mice (n = 8) were trained to discriminate Δ9-THC (10 mg/kg i.p.) from vehicle while responding under a fixed ratio 30 schedule of food presentation. Results Mice satisfied the discrimination criteria in 18–98 (median = 67) sessions and the discriminative stimulus effects of Δ9-THC were dose-dependent (ED50 = 2.6 mg/kg). CP 55940 and WIN 55212-2 dose-dependently increased Δ9-THC-appropriate responding to 100% (ED50 = 0.032 and 0.45 mg/kg, respectively), whereas methanandamide and a variety of noncannabinoids (cocaine, ethanol, and ketamine) produced a maximum of 34% Δ9-THC-appropriate responding. The cannabinoid CB1 antagonist SR 141716A (rimonabant) surmountably antagonized the discriminative effects of Δ9-THC, CP 55940, and WIN 55212-2; methanandamide did not significantly modify the Δ9-THC discriminative stimulus. Conclusions The discriminative stimulus effects of Δ9-THC, CP 55940, and WIN 55212-2 are mediated by the same (i.e., CB1) receptors, whereas the effects of methanandamide or a metabolite of methanandamide are mediated at least in part by non-CB1 receptors. The discriminative stimulus effects of Δ9-THC in mice could be used to evaluate mechanisms of cannabinoid activity with approaches (e.g., inducible knockouts) currently unavailable in nonmurine species.

This publication has 35 references indexed in Scilit: